Here, we seek to evaluate the effect of palbociclib resistance on cell cycle, apoptosis, growth signaling, NF-κB and IKK signaling in Rb-sensitive (MCF7) and Rb-deficient (MDA-MB-468) parental and palbociclib (PLB)-resistant breast cancer cells. Here, RB1 is linked to breast carcinoma.